![Patrick McIlvenny](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patrick McIlvenny
Comptroller/Controller/Auditor presso HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY
Profilo
Patrick McIlvenny is currently working as the Chief Accounting Officer & Senior Vice President at Horizon Therapeutics Plc.
He started this position in 2022.
Prior to his current job, Mr. McIlvenny pursued an undergraduate degree at the University of Ulster.
Posizioni attive di Patrick McIlvenny
Società | Posizione | Inizio |
---|---|---|
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Comptroller/Controller/Auditor | 11/11/2022 |
Formazione di Patrick McIlvenny
University of Ulster | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 1 |
---|---|
Horizon Therapeutics Plc
![]() Horizon Therapeutics Plc Pharmaceuticals: MajorHealth Technology Horizon Therapeutics Plc is a biopharmaceutical company, which engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Inflammation segments. The Orphan segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Patrick McIlvenny